Gelonghui International Industry Co., Ltd. (01143.HK) on August 30thIt was announced that in the first half of 2021, the company achieved revenue of about HK $325 million, year-on-year.Increase by 24.92%Loss attributable to the owner of the company3204.2Ten thousand Hong Kong dollars, year-on-yearNarrow by 54.17%Basic loss per share7.02 Hong Kong cents.
The board of directors and management of the company are committed to developing the existing core business of the Group, actively exploring and looking for new business growth points, especially high-end medical and health services. The Group has set up a joint venture company with strategic partners to develop endometrial stem cell business.